Voyager Therapeutics Company
Voyager Therapeutics is a gene therapy company developing treatments for fatal and debilitating diseases of the central nervous system
Estimated Revenue:
$10M to $50M
Technology:
Neurological Disorders
Industry:
Biotechnology, Health Care, Science and Engineering
Investor Type:
Company
Last Funding Type:
Series B
Total Funding:
135000000
Funding Status:
IPO
Investment Stage:
N/A
Headquarters:
Cambridge, Massachusetts, United States
Investors Number:
7
Number Of Exists:
Series B
Last Funding Date:
13 04 15
Founded Date:
01 01 13
Employee Number:
101-250